feed,title,long_url,short_url
🔐MarketWatch,Aeglea's stock rises after asking the FDA to approve therapy for rare disorder,http://www.marketwatch.com/news/story/aegleas-stock-rises-after-asking/story.aspx?guid=%7B53E26FE6%2DB22C%2D4B1C%2D8467%2D164149123626%7D&siteid=rss,https://on.mktw.net/3uwHpB1
